Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only).: H164-281/1-2019E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.880801&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only). |
| Variant title | Post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only) |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Ligne directrice : changements survenus après l'avis de conformité (AC) : document sur l'innocuité et l'efficacité (pour les produits biologiques, pharmaceutiques et radiopharmaceutiques à usage humain seulement). "Publication date: November 2019." "Pub.: 190400." Issued also in HTML format. |
| Publishing information | Ottawa, ON : Health Canada = Santé Canada, 2019. ©2020 |
| Description | 1 online resource (24 pages) |
| ISBN | 9780660329550 |
| Catalogue number |
|
| Subject terms | Drugs -- Labeling -- Canada. Drug approval -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: